# A DDI Study of JMKX000623 and Metformin Hydrochloride

> **NCT06066060** · PHASE1 · COMPLETED · sponsor: **Jemincare** · enrollment: 24 (actual)

## Conditions studied

- Healthy
- Drug-Drug Interaction

## Interventions

- **DRUG:** JMKX000623
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT06066060
- **Lead sponsor:** Jemincare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-17
- **Primary completion:** 2023-11-06
- **Final completion:** 2023-11-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06066060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06066060, "A DDI Study of JMKX000623 and Metformin Hydrochloride". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06066060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*